PANCURONIUM BROMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Pancuronium Bromide patents expire, and what generic alternatives are available?
Pancuronium Bromide is a drug marketed by Dr Reddys, Elkins Sinn, Hospira, and Igi Labs Inc. and is included in eleven NDAs.
The generic ingredient in PANCURONIUM BROMIDE is pancuronium bromide. There are six drug master file entries for this compound. Additional details are available on the pancuronium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pancuronium Bromide
A generic version of PANCURONIUM BROMIDE was approved as pancuronium bromide by HOSPIRA on January 19th, 1989.
Summary for PANCURONIUM BROMIDE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 59 |
Patent Applications: | 2,642 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PANCURONIUM BROMIDE at DailyMed |
Medical Subject Heading (MeSH) Categories for PANCURONIUM BROMIDE
Anatomical Therapeutic Chemical (ATC) Classes for PANCURONIUM BROMIDE
US Patents and Regulatory Information for PANCURONIUM BROMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dr Reddys | PANCURONIUM BROMIDE | pancuronium bromide | INJECTABLE;INJECTION | 072759-001 | Jul 31, 1990 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hospira | PANCURONIUM BROMIDE | pancuronium bromide | INJECTABLE;INJECTION | 072321-001 | Jan 19, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Elkins Sinn | PANCURONIUM BROMIDE | pancuronium bromide | INJECTABLE;INJECTION | 072059-001 | Mar 23, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |